Medical marijuana is legal in many parts of the U.S.; however, strict federal regulations and administrative obstacles have severely limited research. The result is that millions of Americans are using various forms of medical marijuana without sufficient information on dosing, benefits, and risks. This webinar discusses medical marijuana and related cannabis products, unique challenges and issues for research, and the application of the Common Rule and the Belmont Report’s ethical framework to this research. It also covers practical issues for researchers, IRBs, and institutional administrators.
Update: Now included with the original webinar is an update on marijuana research recorded by Dr. Jane Dumsha on August 12, 2021.
View Series Page for FAQs
Language Availability: English
Suggested Audiences: Human Subject Protection Staff, Institutional Review Boards (IRBs), Institutional/Signatory Officials, Institutions, IRB Administrators and Staff, IRB Chairs, Research Team Members, Researchers
Organizational Subscription Price: $300 per year/per site or included as part of the $1,000 annual subscription to our All Access Webinar Package
Independent Learner Price: $49 per person
Medical Marijuana: A Budding Field of Research
Presented by: Jane Z. Dumsha, PhD, CHES – Philadelphia College of Osteopathic Medicine
This webinar identifies federal regulations and unique issues relevant medical marijuana research. It also discusses how to apply the federal regulations and the Belmont Report’s ethical framework to this research. It concludes with considerations for IRB Review and covers steps for getting started in medical marijuana research.
Recommended Use: Required
ID (Language): 19969 (English)